Lexicon Pharmaceuticals, Inc. (LXRX)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
As of 01:58PM EDT. Market open.
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 438.30M |
| Enterprise Value | 188.97M |
| Trailing P/E | 3.74 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 181.25 |
| Price/Book (mrq) | 1.52 |
| Enterprise Value/Revenue | 81.81 |
| Enterprise Value/EBITDA | -1.07 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 1.27 |
| 52-Week Change 3 | -42.35% |
| S&P500 52-Week Change 3 | 25.38% |
| 52 Week High 3 | 3.7300 |
| 52 Week Low 3 | 0.9200 |
| 50-Day Moving Average 3 | 2.0790 |
| 200-Day Moving Average 3 | 1.6715 |
Share Statistics
| Avg Vol (3 month) 3 | 4.57M |
| Avg Vol (10 day) 3 | 3.22M |
| Shares Outstanding 5 | 246.24M |
| Implied Shares Outstanding 6 | 246.24M |
| Float 8 | 99.98M |
| % Held by Insiders 1 | 1.69% |
| % Held by Institutions 1 | 81.80% |
| Shares Short (Apr 15, 2024) 4 | 20.12M |
| Short Ratio (Apr 15, 2024) 4 | 6.39 |
| Short % of Float (Apr 15, 2024) 4 | 42.17% |
| Short % of Shares Outstanding (Apr 15, 2024) 4 | 8.17% |
| Shares Short (prior month Mar 15, 2024) 4 | 21.35M |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | 1:7 |
| Last Split Date 3 | May 21, 2015 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Mar 31, 2024 |
Profitability
| Profit Margin | 0.00% |
| Operating Margin (ttm) | -4,011.77% |
Management Effectiveness
| Return on Assets (ttm) | -40.08% |
| Return on Equity (ttm) | -102.72% |
Income Statement
| Revenue (ttm) | 2.31M |
| Revenue Per Share (ttm) | 0.01 |
| Quarterly Revenue Growth (yoy) | 4,608.30% |
| Gross Profit (ttm) | N/A |
| EBITDA | -185.36M |
| Net Income Avi to Common (ttm) | -193.58M |
| Diluted EPS (ttm) | -0.8300 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 355.6M |
| Total Cash Per Share (mrq) | 1.44 |
| Total Debt (mrq) | 106.24M |
| Total Debt/Equity (mrq) | 36.78% |
| Current Ratio (mrq) | 15.58 |
| Book Value Per Share (mrq) | 1.17 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -185.41M |
| Levered Free Cash Flow (ttm) | -111.15M |
© 2024 Yahoo. All rights reserved.